Diabetes is one of the leading causes of death. Patients with type 1 diabetes have their insulin secreting cells destroyed by the immune system and require daily insulin injections. Pancreatic islet transplantation is an effective treatment that can dramatically reduce daily doses or even eliminate dependence on external insulin. Insulin producing cells are injected into a recipient liver. After an adaptation period they start to produce sufficient hormone needed by diabetic patients.
However, while the transplantation procedure itself has been greatly improved in recent years, collection, preservation, and transportation of these cells are still very challenging. Research published in Advanced Healthcare Materials by the scientists from the Okinawa Institute of Technology and Science Graduate University (OIST) in collaboration with the University of Washington and Wuhan University of Technology offers a solution for some of these problems.
Production and secretion of insulin occur in the pancreas — an endocrine gland in the digestive system. Cells secreting insulin are clustered in pancreatic islets. Despite their crucial role in organismal wellbeing these islets comprise only a few percent of the pancreatic tissue. The islet transplantation does not require major surgical intervention and is often done under local anaesthesia. It is also cheaper and might be safer than transplantation of the entire pancreas. Unfortunately, so far, only human islets can be transplanted and their supply is but a trickle.
Cryopreservation, or deep freezing, is the method commonly used for the islet preservation and transportation. But it is not completely safe. One might think that storage at temperatures below -190°C is the most dangerous phase. However, the cells are very good at enduring it. It is the freezing process (-15 to -60°C) itself that poses the most challenges. As the cells are cooled, water in and around them freezes. Ice crystals have sharp edges that can pierce membranes and compromise cell viability. This also becomes problematic during thawing.
A multidisciplinary group of researchers led by Prof. Amy Shen, head of the Micro/Bio/Nanofluidics Unit at OIST, developed a novel cryopreservation method that not only helps to protect pancreatic islets from ice damage, but also facilitates real-time assessments of cell viability. Moreover, this method may reduce transplant rejection and, in turn, decrease use of immunosuppressant drugs, which can be harmful to patient health.
The novel technique employs a droplet microfluidic device to encapsulate pancreatic islets in hydrogel made of alginate, a natural polymer extracted from seaweed. These capsules have a unique microstructure: a porous network and considerable amount of non-freezable water. There are three types of water in the hydrogel: free water, freezable bound water, and non-freezable bound water. Free water is regular water: it freezes at 0°C, producing ice crystals. Freezable bound water also crystallises, but the freezing point is lower. Non-freezable bound water does not form ice due to the strong association between water molecules and the hydrogel networks. Hydrogel capsules with large amounts of non-freezable bound water protect the cells from the ice damage and reduce the need for cryoprotectants — special substances that minimise or prevent freezing damage and can be toxic in high concentrations.
Another innovation, proposed by the group, is the use of a fluorescent oxygen-sensitive dye in hydrogel capsules. The porous structure of the capsules does not impede oxygen flow to the cells. And this dye functions as a real-time single-islet oxygen sensor. Fluorescence indicates whether cells are consuming oxygen and, therefore, are alive and healthy. It is a simple, time-efficient, and cheap method of assessing viability, both of individual islets or populations thereof.
Islet encapsulation reduces the risk of rejection of transplanted cells by the recipient. The hydrogel capsule allows small molecules, e.g. nutrients and islet secretions, to pass through the membrane easily, but prevents direct contact between implanted islets and host cells. Encapsulation also may prevent an attack on transplants by the autoimmune response that destroyed the patient’s own islets in the first place.
The microencapsulation method can help to overcome some major challenges in pancreatic islet transplantation, including the scarcity of available islets and the lack of simple and reliable control methods, especially for individual islet assessment. It offers hope to patients suffering from type 1 diabetes to return to a “normal” life, free of insulin injections.
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Fact check: Doctors studying whether COVID-19 could trigger diabeteson June 27, 2020 at 6:58 am
The claim that COVID-19 may trigger diabetes is true. Scientists around the world have launched studies into the connection.
- 'Our diet is killing us quietly': Fiji's diabetes crisison June 26, 2020 at 3:00 pm
Nearly one-third of Fijians have diabetes, and the disease is often not caught until amputation, or even death, are imminent ...
- What is the Medicare Diabetes Prevention Program?on June 26, 2020 at 10:47 am
The MDPP provides training in diet, exercise, and weight management for people who may be at risk of diabetes. It also involves coaching and follow-up sessions.
- Diabetes-Related Amputations on the Rise in Older Adultson June 26, 2020 at 7:18 am
Rates of the 'devastating' complication are increasing in older US adults, a study of Medicare beneficiaries indicates.
- Navigating the LGBTQ Life with Diabeteson June 26, 2020 at 2:26 am
There were times with the diabetes that I wasn’t sure what to expect and didn’t know anybody in the same boat,” says this 38-year-old nurse in Toronto, Canada. “I know everybody is different, but it ...
- Coronavirus and Diabetes: 17 Things Doctors Need Everyone to Knowon June 25, 2020 at 12:38 pm
People with diabetes are at a higher risk of Covid-19 complications. Now there's evidence that Covid-19 might bring on diabetes. Here's what you need to know. The post Coronavirus and Diabetes: 17 ...
- Type 1 Diabetes Prevention Moves Toward Realityon June 25, 2020 at 8:14 am
Teplizumab results extended another year, while other agents are also under study among people with preclinical or new-onset type 1 diabetes.
- 3-D printed insoles offers new hope for patients with diabeteson June 25, 2020 at 7:23 am
D printed insoles can significantly improve the foot health of people suffering with diabetes. This study offers hope for millions of patients with diabetes who are at risk of developing foot ulcers, ...
- Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapyon June 25, 2020 at 6:35 am
This Review highlights the research advances, advantages and challenges in several different strategies for generating functional β-cells for therapeutic use in diabetes mellitus. In addition, ...
- COVID-19 Might Trigger Diabetes In Otherwise Healthy Individuals, Clues Suggeston June 25, 2020 at 6:00 am
Diabetes is known to be an important risk factor for developing severe COVID-19 and those with the condition are more likely to suffer fatalities. But after observing recent COVID-19 cases, experts ...
via Bing News